These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23033840)

  • 21. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
    Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
    Tarnow L; Gall MA; Hansen BV; Hovind P; Parving HH
    Diabetologia; 2006 Oct; 49(10):2256-62. PubMed ID: 16937127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).
    Mitchell A; Misialek JR; Folsom AR; Duprez D; Alonso A; Jerosch-Herold M; Sanchez OA; Watson KE; Sallam T; Konety SH
    Am J Cardiol; 2015 May; 115(10):1341-5. PubMed ID: 25816778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.
    Scharhag J; Herrmann M; Weissinger M; Herrmann W; Kindermann W
    Clin Res Cardiol; 2007 Apr; 96(4):218-26. PubMed ID: 17323015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
    He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
    BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin-2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N-terminal pro-brain natriuretic peptide.
    Jian W; Mo CH; Yang GL; Li L; Gui C
    J Clin Lab Anal; 2019 Oct; 33(8):e22972. PubMed ID: 31257664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
    Rørth R; Jhund PS; Kristensen SL; Desai AS; Køber L; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Eur J Heart Fail; 2019 Jan; 21(1):40-49. PubMed ID: 30537261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NT-proBNP linking low-moderately impaired renal function and cardiovascular mortality in diabetic patients: the population-based Casale Monferrato Study.
    Bruno G; Barutta F; Landi A; Cavallo Perin P; Gruden G
    PLoS One; 2014; 9(12):e114855. PubMed ID: 25503636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
    von Scholten BJ; Reinhard H; Hansen TW; Lindhardt M; Petersen CL; Wiinberg N; Hansen PR; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2015 May; 14():59. PubMed ID: 25990319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.
    Tarnow L; Hildebrandt P; Hansen BV; Borch-Johnsen K; Parving HH
    Diabetologia; 2005 Jan; 48(1):149-55. PubMed ID: 15616804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications.
    Beer S; Golay S; Bardy D; Feihl F; Gaillard RC; Bachmann C; Waeber B; Ruiz J
    Diabetes Metab; 2005 Dec; 31(6):567-73. PubMed ID: 16357805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
    Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.